Published in Oncotarget on August 27, 2016
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell (1996) 16.57
Active genes are tri-methylated at K4 of histone H3. Nature (2002) 15.68
Cancer statistics in China, 2015. CA Cancer J Clin (2016) 12.92
The Polycomb complex PRC2 and its mark in life. Nature (2011) 11.97
The CBP co-activator is a histone acetyltransferase. Nature (1997) 10.91
The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol (2002) 10.59
Integrative analysis of 111 reference human epigenomes. Nature (2015) 10.32
Epithelial-mesenchymal transitions: twist in development and metastasis. Cell (2004) 7.14
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol (1994) 6.00
Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res (2006) 5.90
New signals from the invasive front. Nature (2006) 5.51
Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell (2011) 4.79
Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell (2009) 4.73
Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network. Cell (2011) 4.04
Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92
The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis. Annu Rev Biochem (2012) 3.61
CBP and p300: HATs for different occasions. Biochem Pharmacol (2004) 3.38
Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol (2009) 3.09
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med (2009) 3.05
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol (2011) 3.00
Modeling gene expression using chromatin features in various cellular contexts. Genome Biol (2012) 2.76
Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. Nature (2010) 2.67
Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol Cell Biol (2008) 2.57
An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell (2011) 2.49
International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res (2009) 2.45
Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev Biol (2009) 2.24
G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest (2012) 2.12
Regulation of EMT by TGFβ in cancer. FEBS Lett (2012) 2.11
Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol Cell (2011) 1.94
Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics (2010) 1.92
The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. Int J Cancer (2006) 1.91
Role of Ras signaling in the induction of snail by transforming growth factor-beta. J Biol Chem (2008) 1.83
Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J Biol Chem (2002) 1.80
Inflammation: a driving force speeds cancer metastasis. Cell Cycle (2009) 1.78
Structural basis for cooperative transcription factor binding to the CBP coactivator. J Mol Biol (2005) 1.75
Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res (2011) 1.52
An Ash2L/RbBP5 heterodimer stimulates the MLL1 methyltransferase activity through coordinated substrate interactions with the MLL1 SET domain. PLoS One (2010) 1.52
Jarid1b targets genes regulating development and is involved in neural differentiation. EMBO J (2011) 1.50
H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet (2011) 1.43
Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J Exp Clin Cancer Res (2014) 1.39
Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet (2012) 1.39
SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53. Cell (2013) 1.38
MicroRNAs in colorectal cancer metastasis. J Pathol (2011) 1.36
Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition. Cell Mol Life Sci (2013) 1.30
Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells. Am J Physiol Renal Physiol (2012) 1.26
EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations. Cancer Metastasis Rev (2012) 1.14
Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res (1996) 1.12
Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genomics (2010) 1.10
Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation. Mol Cell (2015) 1.03
Histone modification profiles characterize function-specific gene regulation. J Theor Biol (2012) 1.01
WRAD: enabler of the SET1-family of H3K4 methyltransferases. Brief Funct Genomics (2012) 1.01
trithorax and the regulation of homeotic gene expression in Drosophila: a historical perspective. Int J Dev Biol (1998) 0.96
G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget (2015) 0.95
Context dependency of Set1/COMPASS-mediated histone H3 Lys4 trimethylation. Genes Dev (2014) 0.91
dKDM5/LID regulates H3K4me3 dynamics at the transcription-start site (TSS) of actively transcribed developmental genes. Nucleic Acids Res (2012) 0.90
Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes. Oncotarget (2016) 0.89
Structural basis for activity regulation of MLL family methyltransferases. Nature (2016) 0.89
Transforming growth factor-β1 inhibits trophoblast cell invasion by inducing Snail-mediated down-regulation of vascular endothelial-cadherin protein. J Biol Chem (2013) 0.87
Chromatin Remodelers: From Function to Dysfunction. Genes (Basel) (2015) 0.86
Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression. Oncotarget (2016) 0.78
Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells. Med Oncol (2016) 0.76
Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway. Mol Med Rep (2014) 0.89
MicroRNA-124 regulates TGF-α-induced epithelial-mesenchymal transition in human prostate cancer cells. Int J Oncol (2014) 0.88
DNA methylation inhibitor, decitabine, promotes MGC803 gastric cancer cell migration and invasion via the upregulation of NEDD4‑1. Mol Med Rep (2015) 0.76
Upregulation of fractalkine contributes to the proliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition. Mol Med Rep (2015) 0.76
CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen‑independent prostate cancer cells. Oncol Rep (2015) 0.76